@lifescience

Powered by CG Life, the Life Science Network (LSN) is a relaxed community of life science professionals, researchers, communicators, marketers and advocates.

cglife.com/life-science-network/
Joined June 2012
  • Tweets9.3K
  • Following1.3K
  • Followers2.8K
2.7KMedia
A fabulous, complimentary life science networking reception is coming up during Advances in Single Cell & Spatial Biology on 9/14. CG Life is co-hosting. It should make for an excellent evening of drinks, bites, and science! buff.ly/3LdiP0d
1
1
288
Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal buff.ly/3Ft8vxH
194
New Cancer Therapy Target Stops Tumor Cells From Sharing Resources buff.ly/3tCcmWK
174
Oncolytic Virus Improves Survival in Glioblastoma Trial buff.ly/45BGyyn via @GENbio
166
Seed-stage Bay Area biotechs kick off return of BIO Investor Forum - San Francisco Business Times buff.ly/3M8fMGS via @SFBusinessTimes
110
Carl Icahn sues Illumina board members over Grail acquisition - buff.ly/3M7viTk
1
131
Flipped coins found not to be as fair as thought buff.ly/3tzxYmw via @physorg_com
74
Aldeyra braces for potential dry eye disease rejection after FDA says more data are necessary - buff.ly/3M7323n
76
These Japanese life science firms came to San Diego to study startups buff.ly/3S3eP6t
1
1
112
Better Therapeutics begins rolling out digital app for Type 2 diabetes buff.ly/3ZYlsJi
54
Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug buff.ly/3FkOLMQ
76
Thermo Fisher Scientific to buy Olink in $3.1 billion deal reuters.com/markets/deals/th…

Thermo Fisher Scientific to buy Olink in $3.1 billion deal

Thermo Fisher Scientific would acquire Olink Holding AB in a deal valued at $3.1 billion, the companies said on Tuesday, as the U.S. medical equipment maker seeks to boost its life sciences portfolio...

reuters.com
50
Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup - buff.ly/3trFVtR
55
Life Science Network retweeted
Gwendolyn Wu@gwendolynawu11 Oct 2023
A decade later, biotech’s CRISPR revolution is still going strong. I traced the history of gene editing startups and what it means for the future. The result? A deep dive into the schools and scientists who mold the future of medicine. For @BioPharmaDive biopharmadive.com/news/crisp…

A decade later, biotech’s CRISPR revolution is still going strong

Once the specialty of a few select drugmakers, CRISPR gene editing is now an essential technology for a growing group of biotechs, many led by former students of the field's pioneering scientists.

biopharmadive.com
2
4
254
Chemogenetics Can Dampen Pain Responses in Lab Tests buff.ly/3tp55t9 via @clinicalomics
61
Cell Therapy for Drug-Resistant Epilepsy a Preclinical Success buff.ly/46FyPA6 via @GENbio
1
1
87
Twist Bioscience, Bayer Enter Antibody Discovery Deal Valued at up to $188 Million buff.ly/3LJR6Ve via @clinicalomics
49
Life Science Network retweeted
CG Life@cglifeagency5 Oct 2023
Researchers are using CRISPR for more complex diseases such as Alzheimer's. Studies done at @UCSanDiego, @DukeU, and more are using CRISPR to target genes found in properties responsible for the disease. Read more from @DrewQJoseph at @statnews: bit.ly/44LOmxw
1
2
114
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone $ETON buff.ly/45xS1zb via $ETON
108
BridgeBio and Resilience Form Gene Therapy Partnership buff.ly/3Qd3ZtD via @GENbio
41
Gilead stops another CD47 study, this time in acute myeloid leukemia - buff.ly/46riCPc
49
Load more